Dalatic Injection 600 mg/4 ml contains Clindamycin, a broad-spectrum lincosamide antibiotic used for the treatment of serious bacterial infections caused by susceptible organisms. Unlike oral formulations, this intravenous or intramuscular injection is ideal for patients who cannot take oral medications or require rapid therapeutic levels, such as in severe infections or hospital settings.
Dalatic Injection 600 mg/4 ml is formulated to provide quick and effective antibacterial action against Gram-positive cocci and anaerobic bacteria, making it suitable for a wide range of systemic, intra-abdominal, respiratory, and soft tissue infections. Its precise dosing ensures optimal efficacy and safety in critically ill patients.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Clindamycin, the active ingredient in Dalatic Injection, works through:
Inhibition of bacterial protein synthesis: Clindamycin binds to the 50S subunit of bacterial ribosomes, preventing peptide chain elongation and protein formation.
Bacteriostatic or bactericidal effects: It primarily inhibits bacterial growth (bacteriostatic) but can be bactericidal against certain strains at higher concentrations.
Targeting anaerobic and Gram-positive bacteria: Effective against pathogens like Staphylococcus aureus, Streptococcus species, and anaerobes in the gastrointestinal and soft tissue systems.
This mechanism allows Dalatic Injection to rapidly control infection and prevent the spread of bacteria in the body.
Dalatic Injection 600 mg/4 ml is indicated for the treatment of:
Severe respiratory tract infections – pneumonia, bronchitis, and sinusitis
Skin and soft tissue infections – cellulitis, abscesses, and infected wounds
Bone and joint infections – including osteomyelitis
Intra-abdominal infections – peritonitis, pelvic infections, and abscesses caused by anaerobic bacteria
Severe dental infections – including periodontitis and abscesses
Other serious bacterial infections where oral therapy is not feasible
It is particularly valuable in patients allergic to penicillin or those who need rapid intravenous therapy for systemic infections.
Administered intravenously (IV) or intramuscularly (IM) under medical supervision.
Typical adult IV dose: 600 mg every 8 hours, infused slowly over 10–60 minutes to minimize local irritation and adverse effects.
IM administration should be given deep into a large muscle mass.
Dosing adjustments may be necessary for patients with renal or hepatic impairment.
Therapy duration depends on infection severity and should be guided by a physician.
Monitor patients for allergic reactions, particularly those with a history of hypersensitivity to lincosamides.
Use caution in individuals with liver or kidney disease, or a history of gastrointestinal disorders.
Dalatic Injection may cause Clostridium difficile-associated diarrhea, which can be severe and requires prompt medical attention.
Avoid extravasation during IV administration to prevent tissue irritation or necrosis.
Inform your doctor about all concurrent medications to prevent drug interactions.
Common side effects include:
Local reactions – pain, swelling, or redness at the injection site
Gastrointestinal issues – nausea, vomiting, or diarrhea
Allergic reactions – rash, itching, or rarely, anaphylaxis
Neurological symptoms – dizziness or headache
Rare but serious: pseudomembranous colitis caused by Clostridium difficile
Most side effects are manageable under medical supervision and typically resolve with dose adjustment or completion of therapy.
Store Dalatic Injection 600 mg/4 ml in a cool, dry place, protected from light. Keep out of reach of children. Use only if the solution is clear and free of particulates.
Dalatic Injection 600 mg/4 ml provides rapid and effective antibacterial therapy, essential for managing severe infections and supporting patient recovery in clinical settings.
Login Or Registerto submit your questions to seller
No none asked to seller yet